You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA2 protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
Dec 19, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

    Completed
    Has Results
    • Breast Neoplasms
    • KU-0059436 (AZD2281) (PARP inhibitor)
    • West Hollywood, California
    • +16 more
    Jan 24, 2023

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +51 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 15, 2022

    Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Mesothelioma
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 1, 2023

    Breast Cancer Trial in New York (core needle biopsy, blood draw)

    Recruiting
    • Breast Cancer
    • core needle biopsy
    • blood draw
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Nov 9, 2023

    Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Biospecimen Collection
    • +6 more
    • (no location specified)
    Mar 28, 2023

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by

    Completed
    • Breast Cancer
    • Blood test
    • Questionnaire
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 27, 2021

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Type 2 Diabetes Trial in Limerick (Seaweed protein, Maltodextrin)

    Not yet recruiting
    • Type 2 Diabetes
    • Seaweed protein
    • Maltodextrin
    • Limerick, Ireland
      University of Limerick
    Aug 14, 2023

    Protein Metabolism Disorder Trial in Maastricht (20g whey protein drink ingestion, 20g native canola protein drink ingestion,

    Recruiting
    • Protein Metabolism Disorder
    • 20g whey protein drink ingestion
    • +3 more
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Centre+
    Sep 21, 2023

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022